You are here

AstraZeneca

AstraZeneca, Daiichi aim for first pan-tumor ADC approval

BioPharma Dive

Mon, 01/29/24 - 11:25 am

antibody-drug conjugate

Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs

Fierce Biotech

Wed, 01/24/24 - 10:35 am

Synnovation Therapeutics

PARP inhibitors

AstraZeneca reports positive data from Phase III trial of Imfinzi

Clinical Trials Arena

Mon, 01/22/24 - 11:29 am

clinical trials

hepatocellular carcinoma

BioNTech challenges AstraZeneca with breast cancer precision drug trial

Reuters

Mon, 01/22/24 - 11:15 am

Duality Biologics

clinical trials

HER2+ breast cancer

AZ bags first approval for PNH therapy danicopan, in Japan

Pharmaphorum

Fri, 01/19/24 - 09:38 am

IRA lawsuits will be vital test of US’ ability to regulate pharma market

Clinical Trials Arena

Wed, 01/17/24 - 09:41 am

Inflation Reduction Act

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

Reuters

Fri, 01/5/24 - 11:25 am

Bristol Myers Squibb

Carmot Therapeutics

AstraZeneca picks up a friend for Tagrisso in $40M upfront deal

Fierce Biotech

Tue, 01/2/24 - 10:05 pm

Allorion Therapeutics

Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche

BioSpace

Tue, 01/2/24 - 11:26 am

Gracell Biotechnologies

Bristol Myers Squibb

AZ, Sanofi’s Beyfortus cleared in China for RSV prevention

Pharmaphorum

Tue, 01/2/24 - 10:09 am

AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases

BioSpace

Wed, 12/27/23 - 11:08 pm

FDA approves Ionis-AstraZeneca's nerve disease drug

Reuters

Fri, 12/22/23 - 09:42 am

Ionis Pharmaceuticals

AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market

Reuters

Thu, 12/14/23 - 10:48 pm

AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase

BioSpace

Tue, 12/12/23 - 11:17 am

ASH: With high tumor response, AstraZeneca spinout Dizal explores FDA path and US partner for PTCL drug

Fierce Biotech

Mon, 12/11/23 - 10:09 am

Dizal Pharmaceutical

peripheral T cell lymphoma

clinical trials

ASH: As Novartis enters PNH market, AstraZeneca shows longer term effect of its latest contender

Fierce Biotech

Mon, 12/11/23 - 10:07 am

AstraZeneca Just Joined the AI Drug Development Craze

Motley Fool

Sun, 12/10/23 - 11:08 pm

drug development

artificial intelligence

FTC warns pharma companies on excessive drug patenting

Medical Marketing and Media

Fri, 12/8/23 - 10:05 am

Teva Pharmaceutical

For Merck, Lynparza fails to improve on Keytruda in first-line lung cancer

Fierce Pharma

Thu, 12/7/23 - 12:00 pm

non-small cell lung cancer

3 standout digital innovations in pharma this year

Pharma Voice

Mon, 12/4/23 - 09:44 am

Boehringer Ingelheim

Pages